title: To whom is HIV pre-exposure prophylaxis proposed?
abstract: BACKGROUND
  HIV Pre-Exposure Prophylaxis (PrEP) consists of administering antiretroviral drugs to seronegative individuals with high risk practices. The aim of the study was to describe the characteristics of recent seroconverted HIV patients in order to determine the profile of the appropriate candidates for PrEP.
  
  
  METHODS
  A descriptive study of all patients diagnosed with HIV infection in 2014, and who had achieved a documented negative serology over the previous 12 months. A specific form was completed to determine the sociodemographic, behavioural, and clinical features, with complementary tests being performed for other sexually transmitted infections.
  
  
  RESULTS
  Almost all (98.4%) of the 61 recent seroconverted were men who have sex with men, and aged between 20 to 39 years (88.5%). They also had a background of sexually transmitted infections (80.3%), performed multiple and unprotected sexual practices (82.7%), and under the effect of recreational drugs (87%).
  
  
  CONCLUSIONS
  The evaluation of the risk factors for HIV infection in seronegative patients should enable the appropriate candidates for PrEP to be identified.
authors.affiliation: Servicio de Urgencias, Hospital Fundación Jiménez Díaz, Madrid, España; Unidad de ITS/VIH, Centro Sanitario Sandoval IdISSC, Madrid, España. Electronic address: oskarayerdi@hotmail.com.
authors.forename: Oskar
authors.initials: O
authors.lastname: Ayerdi-Aguirrebengoa
authors.affiliation: Unidad de ITS/VIH, Centro Sanitario Sandoval IdISSC, Madrid, España.
authors.forename: Mar
authors.initials: M
authors.lastname: Vera-García
authors.affiliation: Unidad de ITS/VIH, Centro Sanitario Sandoval IdISSC, Madrid, España.
authors.forename: Teresa
authors.initials: T
authors.lastname: Puerta-López
authors.affiliation: Unidad de ITS/VIH, Centro Sanitario Sandoval IdISSC, Madrid, España.
authors.forename: Montserrat
authors.initials: M
authors.lastname: Raposo-Utrilla
authors.affiliation: Unidad de ITS/VIH, Centro Sanitario Sandoval IdISSC, Madrid, España.
authors.forename: Carmen
authors.initials: C
authors.lastname: Rodríguez-Martín
authors.affiliation: Unidad de ITS/VIH, Centro Sanitario Sandoval IdISSC, Madrid, España.
authors.forename: Jorge
authors.initials: J
authors.lastname: Del Romero-Guerrero
mesh_terms: D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015897:Comorbidity; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006679:HIV Seropositivity; D018451:Homosexuality, Male; D006801:Humans; D013287:Illicit Drugs; D008297:Male; D008875:Middle Aged; D065129:Pre-Exposure Prophylaxis; D012307:Risk Factors; D012725:Sexual Behavior; D012747:Sexual Partners; D012749:Sexually Transmitted Diseases / Q000453:epidemiology; D012876:Skin Diseases, Parasitic / Q000453:epidemiology; D013030:Spain; D019966:Substance-Related Disorders / Q000453:epidemiology; D047568:Unsafe Sex; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents; D013287:Illicit Drugs
keywords: Human immunodeficiency virus; Pre-exposure prophylaxis; Profilaxis pre-exposición; Recent seroconvertor; Seroconvertores recientes; Virus de la inmunodeficiencia humana